Department of Medicine, Mayo Clinic, Phoenix, AZ.
Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ.
Transplantation. 2019 Sep;103(9):e263-e272. doi: 10.1097/TP.0000000000002792.
Kidneys from deceased donors with acute kidney injury (AKI) are more likely to be discarded because of concerns for poor outcomes after transplantation. The aim of this study was to determine the long-term outcomes of a large cohort of patients transplanted utilizing kidneys from deceased donors with AKI.
All patients receiving a deceased donor kidney transplant during a recent 10-year period were included. Acute Kidney Injury Network (AKIN) criteria were used to classify the donors. Donor kidneys with >10% cortical necrosis or more than mild chronic changes were discarded. The primary outcome is the combined endpoint of death or graft loss.
The cohort included 1313 kidneys from 974 donors, AKIN stage 0 (no AKI) in 319 (24.3%), stage 1 in 370 (28.2%), stage 2 in 177 (13.5), and stage 3 in 447 (34.0%). Estimated 5-year graft survival (95% confidence interval) was 78.5% (72.5-84.5), 77.8% (72.8-82.1), 83.8% (76.8-88.9), and 84.6% (79.5-88.7) for AKIN donor stage 0 to 3, respectively (log-rank P = 0.10). After adjusting for baseline differences, the hazard ratio (95% confidence interval) for the combined endpoint for the AKIN stage 3 group (relative to AKIN 0 group) was 0.70 (0.45-1.10). Delayed graft function occurred in 44.6% and 75.4% of AKIN 2 and 3 groups, as compared to 33.9% and 33.5% in AKIN 0 and 1 (P < 0.001).
We conclude that transplanting selected kidneys from deceased donors with AKI with preimplantation biopsy showing <10% cortical necrosis and no more than mild chronic changes have excellent long-term graft survival.
由于担心移植后结局不佳,来自发生急性肾损伤(AKI)的已故供者的肾脏更有可能被丢弃。本研究旨在确定利用发生 AKI 的已故供者肾脏进行大量患者移植的长期结果。
纳入了最近 10 年期间接受过已故供者肾移植的所有患者。采用急性肾损伤网络(AKIN)标准对供者进行分类。丢弃皮质坏死>10%或伴有明显慢性改变的供者肾脏。主要结局是死亡或移植物丢失的联合终点。
该队列包括 974 名供者的 1313 个肾脏,AKIN 0 期(无 AKI)319 个(24.3%),1 期 370 个(28.2%),2 期 177 个(13.5%),3 期 447 个(34.0%)。估计 5 年移植物存活率(95%置信区间)分别为 AKIN 0 至 3 期的 78.5%(72.5-84.5)、77.8%(72.8-82.1)、83.8%(76.8-88.9)和 84.6%(79.5-88.7)(对数秩 P = 0.10)。在校正基线差异后,AKIN 3 期组(与 AKIN 0 期组相比)的联合终点风险比(95%置信区间)为 0.70(0.45-1.10)。AKIN 2 期和 3 期组的延迟移植物功能发生率分别为 44.6%和 75.4%,而 AKIN 0 期和 1 期组分别为 33.9%和 33.5%(P < 0.001)。
我们的结论是,对移植前活检显示皮质坏死<10%且伴有轻度慢性改变的 AKI 已故供者的肾脏进行选择,并进行移植,可获得极好的长期移植物存活率。